Onconetix (ONCO) Amortizatization of Intangibles (2023 - 2025)
Onconetix (ONCO) posted quarterly Amortizatization of Intangibles of $3922.0 for Q4 2025, down 22.83% year-over-year from $5082.0 in Q4 2024, and down 96.08% quarter-over-quarter from $100000.0 in Q3 2025.
Onconetix (ONCO) Amortizatization of Intangibles (2023 - 2025) Analysis & Trends
Onconetix (ONCO) has reported Amortizatization of Intangibles for 3 consecutive years, with $3922.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Amortizatization of Intangibles fell 22.83% year-over-year to $3922.0; the TTM figure through Dec 2025 stood at $108888.0 (down 71.09% YoY), while the FY2025 annual figure was $124084.0, down 67.06% from the prior year.
- Amortizatization of Intangibles fell to $3922.0 in Q4 2025 per ONCO's latest filing, from $100000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $269097.0 in Q3 2023 and bottomed at $3922.0 in Q4 2025.
- Historically, Amortizatization of Intangibles has averaged $104769.4 across 3 years, with a median of $100000.0 in 2025.
- Annual changes were most pronounced in 2024 — Amortizatization of Intangibles tumbled 97.3% — and 2025, when it gained 25.6%.
- Onconetix's Amortizatization of Intangibles stood at $188280.0 in 2023, then sank by 97.3% to $5082.0 in 2024, then decreased by 22.83% to $3922.0 in 2025.
- Business Quant data shows ONCO's Amortizatization of Intangibles at $3922.0 in Q4 2025, $100000.0 in Q3 2025, and $4966.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 678,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Onconetix | 1.44 Mn | -4.50 Mn | 4,303.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,922.00 |
| Dec 31, 2025 | 3,922.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 4,966.00 |
| Mar 31, 2025 | 4,966.00 |
| Dec 31, 2024 | 5,082.00 |
| Dec 31, 2024 | 5,082.00 |
| Sep 30, 2024 | 79,619.00 |
| Sep 30, 2024 | 79,619.00 |
| Jun 30, 2024 | 109,031.00 |
| Jun 30, 2024 | 109,031.00 |
| Mar 31, 2024 | 182,928.00 |
| Mar 31, 2024 | 182,928.00 |
| Dec 31, 2023 | 188,280.00 |
| Dec 31, 2023 | 188,280.00 |
| Sep 30, 2023 | 269,097.00 |
| Sep 30, 2023 | 269,097.00 |